Ursodeoxycholic acid sodium
CAS No. 2898-95-5
Ursodeoxycholic acid sodium( Ursodeoxycholate sodium | UDCA sodium | UDCA Na | Sodium Ursodeoxycholate | Ursodeoxycholic Acid (sodium salt) )
Catalog No. M27933 CAS No. 2898-95-5
Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUrsodeoxycholic acid sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrsodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
-
DescriptionUrsodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
-
In Vitro——
-
In VivoUrsodeoxycholic acid (50, 150, and 450 mg/kg; p.o.; daily for 21 days) sodium results in weight loss in C57BL/6J wildtype mice. Animal Model:5 week old C57BL/6J WT mice (male and female)Dosage:50, 150, and 450 mg/kg dissolved in corn oilAdministration:Oral gavage; daily for 21 days Result:Mice in the 50 and 450 mg/kg groups sustained significant weight loss within a week. At 50 mg/kg, this weight loss persisted over the course of the experiment. At 450 mg/kg, initially weight loss was noted during the first and third week of ursodiol administration. At 150 mg/kg, it did not have significantly different weights compared to the untreated mice.
-
SynonymsUrsodeoxycholate sodium | UDCA sodium | UDCA Na | Sodium Ursodeoxycholate | Ursodeoxycholic Acid (sodium salt)
-
PathwayMetabolic Enzyme/Protease
-
TargetFXR
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2898-95-5
-
Formula Weight414.562
-
Molecular FormulaC24H39NaO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (301.53 mM)
-
SMILES[H][C@@]12CC[C@H]([C@H](C)CCC(=O)O[Na])[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@]2([H])C[C@H](O)CC[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tehrani K , Hashemi M , Hassan M , et al. Synthesis and antibacterial activity of Schiff bases of 5-substituted isatins. Chinese Chemical Letters, 2016.
molnova catalog
related products
-
MFA-1
MFA-1 (Merck FXR agonist 1) is a potent, synthetic FXR agonist with EC50 of 16.9 nM in coactivator recruitment assays.
-
GSK-2324
GSK-2324 (GSK2324)?is a potent, selective, full FXR agonist with EC50 of 120 nM in FRET assay.
-
Cilofexor
Cilofexor (GS-9674, GS9674, PX-104)?is a novel specific, non-steroidal farnesoid X receptor (FXR) agonist that reduces liver fibrosis and ameliorates portal hypertension in rat NASH models.
Cart
sales@molnova.com